Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Share-based Compensation came in at $12.6 million in Q2 2026, down 44.49% on a YoY basis from $22.7 million in Q2 2025, and up 10.53% quarter-over-quarter from $11.4 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Share-based Compensation for 5 consecutive years, with $12.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation fell 44.49% year-over-year to $12.6 million; the trailing twelve-month figure through Jun 2026 stood at $61.1 million (down 6.86% YoY), and the FY2025 full-year result was $74.4 million, up 27.4% from the prior year.
  • Share-based Compensation rose to $12.6 million in Q2 2026 per FTRE's latest filing, from $11.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $22.7 million in Q2 2025 and bottomed at $5.8 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $13.2 million across 5 years, with a median of $13.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Share-based Compensation surged 167.24% in 2023, then slumped 44.49% in 2026.
  • Over 5 years, Share-based Compensation stood at $5.8 million in 2022, then soared by 167.24% to $15.5 million in 2023, then retreated by 1.29% to $15.3 million in 2024, then dropped by 3.27% to $14.8 million in 2025, then slipped by 14.86% to $12.6 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $12.6 million, $11.4 million, and $14.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 95.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 4.35 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 19.78 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 18.46 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 12.60 Mn
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 7.60 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 357,000.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn 590,899.88
10 VivoSim Labs 1.47 Mn 1.47 Mn - 91,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.60 Mn
Mar 31, 2026 11.40 Mn
Dec 31, 2025 14.80 Mn
Sep 30, 2025 22.30 Mn
Jun 30, 2025 22.70 Mn
Mar 31, 2025 14.60 Mn
Dec 31, 2024 15.30 Mn
Sep 30, 2024 13.00 Mn
Jun 30, 2024 15.00 Mn
Mar 31, 2024 15.10 Mn
Dec 31, 2023 15.50 Mn
Sep 30, 2023 11.10 Mn
Jun 30, 2023 9.40 Mn
Mar 31, 2023 6.70 Mn
Dec 31, 2022 5.80 Mn
Sep 30, 2022 6.40 Mn